Comprehensive Respiratory Pathogens Testing

NxGen MDx has been in the fight against COVID-19 since early 2020, quickly developing and launching a COVID test that March. Since then, NxGen MDx has expanded respiratory testing options to account for the many flu season pathogens that have symptomatic overlap with COVID. When you need fast and comprehensive answers for a respiratory infection, look to NxGen MDx.

Understanding Respiratory Symptoms

Many respiratory infections, such as COVID-19 and the flu, share similar symptoms which can be hard to distinguish on your own. Testing from NxGen MDx can identify the specific pathogen causing your illness and provide you guidance on whether you are ok to return to work/school, if there are any antibiotics or medications that will help, or if you just need bed rest.

COVID-19, Influenza, and RSV share many overlapping symptoms.

Risks of Respiratory Infections

Respiratory pathogens are some of the most common causes of infection with illness ranging from mild (such as the common cold) to potentially deadly (such as RSV or COVID-19). Comprehensive testing can help you understand your level of risk and infectiousness.

Average of 31.6 million flu cases per year since 20151

160,000+ RSV infections detected since spikes started in mid 20212

Yearly strep infections estimated at 14,000 – 25,0003

Access for All

We want our panels and tests to be affordable for everyone. If you are uninsured or think you will have difficulty paying for your screening or testing, our Access for All Program may be able to help.


Interested in the NxGen MDx Respiratory Pathogen Panel?

The Answers Your Patients Need with One Test

Respiratory illnesses can be attributed to a multitude of pathogens. When a negative COVID-19 test isn’t enough and your patient needs answers, the comprehensive Respiratory Pathogen Panel (RPP) can provide a diagnosis.

A Larger Panel Means More Patients with a Positive Diagnosis1

A larger panel like the RPP has a 86.2% positive rate.

Follow the CDC’s recommendations for multipathogen testing and put your patient’s mind at ease.2,3

Tests for 99% of community-acquired infections

Simultaneous antiviral & antibiotic resistance testing

Treatment guidelines for individual pathogens included on each report4

Included in NxGen’s Respiratory Pathogen Panel

Viral Respiratory Pathogens

  • Adenovirus
  • COVID-19
  • Human Bocavirus
  • Human Coronavirus 229E, HKU1, NL63, and OC43
  • Human Enterovirus Pan Assay (plus D68)
  • Human Metapneumovirus (hMPV)
  • Human Parainfluenza Virus 1-4
  • Human Herpesvirus 3 (Varicella Zoster Virus)
  • Human Herpesvirus 4 (Epstein-Barr Virus)
  • Human Herpesvirus 5 (Cytomegalovirus)
  • Human Herpesvirus 6
  • Human Respiratory Syncytial Virus A
  • Human Respiratory Syncytial Virus B
  • Human Rhinovirus
  • Influenza A (plus H1-2009 & H3)
  • Influenza B

Bacterial Respiratory Pathogens

  • Bordetella pertussis
  • Bordetella spp. (bronchiseptica, parapertussis)
  • Chlamydia pneumoniae
  • Haemophilus Influenzae
  • Klebsiella pneumoniae
  • Legionella pneumophila
  • Mycoplasma pneumoniae
  • Staphylococcus aureus
  • Streptococcus pneumoniae
  • Streptococcus Pyogenes (Group A Strep)*

Antibiotic & Antiviral Resistances Tested

  • Betalactam/Beta-lactamase
  • Inhibitor Combination Drugs
  • Carbapenems
  • Extended Spectrum Beta-lactams
  • Macrolides
  • Methicillin
  • Neuraminidase Inhibitor
  • (Oseltamivir/ Zanamivir/ Peramivir)
  • Penicillins & Cephalosporins
  • Quinolone/Fluoroquinolone
  • Sulfamethoxazole & Trimethoprim (SMX/TMP)
  • Vancomycin

*Available as an add-on assay. Paired sampling is required (NP+Oropharyngeal or Nasal+Oropharyngeal).

Empowering Antibiotic Stewardship

Comprehensive testing of viral pathogens reassures patients and families when antibiotics are not needed. When bacterial pathogens are detected, antibiotic resistance and treatment guidelines are included on the report. Infectious disease experts are available for advice on both viral and bacterial infections.

23.9% of bacteria-positive cases showed evidence of antibiotic resistance.1

The NxGen MDx Respiratory Pathogens Panel Benefits You and Your Patients

Partnering with NxGen MDx has positively impacted my clinical practice and patient outcomes.

Leslie Biggs

NP, Peachtree Internal Medicine

Excellent customer service and any question or concern is always addressed in less than twenty-four hours. Thank you NxGen MDx!

Leslie Biggs

NP, Peachtree Internal Medicine

Connect With Us

If you are interested in offering the NxGen MDx Respiratory Pathogens Panel or simply want to learn more, click the button below to contact a NxGen representative.